SCOPUS 정보 검색 플랫폼

Climacteric

Volumn 15, Issue 6, 2012, Pages 607-610

Clinically meaningful efficacy of a non-estrogen agent: Re-analysis of phase-2 data evaluating MF101

(7) Tagliaferri, M a Creasman, J b Caygill, K A a Olyaie, A a Leitman, D c Cohen, I a Grady, D b,d

a Bionovo Inc (United States)

b UCSF Women's Health Clinical Research Center (United States)

c UNIVERSITY OF CALIFORNIA (United States)

d UNIVERSITY OF CALIFORNIA (United States)

Author keywords

HORMONE THERAPY; HOT FLUSH; MENOPAUSE; MF101; VASOMOTOR SYMPTOM

Indexed keywords

ESTROGEN RECEPTOR BETA; MF 101; PLACEBO; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HOT FLUSH; HUMAN; MAJOR CLINICAL STUDY; PATIENT SATISFACTION; PHASE 2 CLINICAL TRIAL; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE;

ADULT; DOUBLE-BLIND METHOD; ESTROGEN RECEPTOR BETA; FEMALE; HOT FLASHES; HUMANS; MIDDLE AGED; PLACEBOS; PLANT EXTRACTS; TREATMENT OUTCOME;

EID: 84862300195 PISSN: 13697137 EISSN: 14730804 Source Type: Journal
DOI: 10.3109/13697137.2011.630113 Document Type: Article

Times cited : (3)

References (10)

1
- 0028224783
- Hot flashes: Phenomenology, quality of life, and search for treatment options
- DOI 10.1016/0531-5565(94)90012-4
- Kronenberg F. Hot flashes: phenomenology, quality of life, and search for treatment options. Exp Gerontol 1994;29:319-36 (Pubitemid 24211138)
- (1994) Experimental Gerontology , vol.29 , Issue.3-4 , pp. 319-336
- Kronenberg, F.¹

2
- 0034992739
- Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate
- DOI 10.1016/S0015-0282(01)01791-5, PII S0015028201017915
- Utian WH, Shoupe D, Bachmann G, Pinkerton JV, Pickar JH. Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate. Fertil Steril 2001;75:1065-79 (Pubitemid 32522600)
- (2001) Fertility and Sterility , vol.75 , Issue.6 , pp. 1065-1079
- Utian, W.H.¹ Shoupe, D.² Bachmann, G.³ Pinkerton, J.V.⁴ Pickar, J.H.⁵

3
- 0033624858
- Initial 17β-Estradiol dose for treating vasomotor symptoms
- DOI 10.1016/S0029-7844(99)00643-2, PII S0029784499006432
- Notelovitz M, Lenihan JP, McDermott M, Kerber IJ, Nanavati N, Arce J. Initial 17beta-estradiol dose for treating vasomotor symptoms. Obstet Gynecol 2000;95:726-31 (Pubitemid 30210060)
- (2000) Obstetrics and Gynecology , vol.95 , Issue.5 , pp. 726-731
- Notelovitz, M.¹ Lenihan Jr., J.P.² McDermott, M.³ Kerber, I.J.⁴ Nanavati, N.⁵ Arce, J.-C.⁶

4
- 0038521433
- Botanical dietary supplement use in peri- and postmenopausal women
- DOI 10.1097/00042192-200310010-00011
- Mahady GB, Parrot J, Lee C, Yun GS, Dan A. Botanical dietary supplement use in peri- and postmenopausal women. Menopause 2003;10:65-72 (Pubitemid 36706324)
- (2003) Menopause , vol.10 , Issue.1 , pp. 65-72
- Mahady, G.B.¹ Parrot, J.² Lee, C.³ Yun, G.S.⁴ Dan, A.⁵

5
- 0036827790
- Ethnic differences in use of complementary and alternative medicine at midlife: Longitudinal results from SWAN participants
- Bair YA, Gold EB, Greendale GA, et al. Ethnic differences in use of complementary and alternative medicine at midlife: longitudinal results from SWAN participants. Am J Public Health 2002;92:1832-40 (Pubitemid 35231148)
- (2002) American Journal of Public Health , vol.92 , Issue.11 , pp. 1832-1840
- Bair, Y.A.¹ Gold, E.B.² Greendale, G.A.³ Sternfeld, B.⁴ Adler, S.R.⁵ Azari, R.⁶ Harkey, M.⁷

6
- 67649866374
- MF101, a selective estrogen receptor beta modulator for the treatment of menopausal hot flushes: A phase II clinical trial
- Grady D, Sawaya GF, Johnson KC, et al. MF101, a selective estrogen receptor beta modulator for the treatment of menopausal hot flushes: a phase II clinical trial. Menopause 2009;16:458-65
- (2009) Menopause , vol.16 , pp. 458-465
- Grady, D.¹ Sawaya, G.F.² Johnson, K.C.³

7
- 0035576115
- Methodologic lessons learned from hot flash studies
- Sloan JA, Loprinzi CL, Novotny PJ, Barton DL, Lavasseur BI, Windschitl H. Methodologic lessons learned from hot flash studies. J Clin Oncol 1 2001;19:4280-90 (Pubitemid 33096775)
- (2001) Journal of Clinical Oncology , vol.19 , Issue.23 , pp. 4280-4290
- Sloan, J.A.¹ Loprinzi, C.L.² Novotny, P.J.³ Barton, D.L.⁴ Lavasseur, B.I.⁵ Windschitl, H.⁶

8
- 34247586185
- Minimal decrease in hot flashes desired by postmenopausal women in family practice
- DOI 10.1097/01.gme.0000235370.32103.4c
- Butt DA, Deng LY, Lewis JE, Lock M. Minimal decrease in hot flashes desired by postmenopausal women in family practice. Menopause 2007;14:203-7 (Pubitemid 46673470)
- (2007) Menopause , vol.14 , Issue.2 , pp. 203-207
- Butt, D.A.¹ Deng, L.Y.R.² Lewis, J.E.³ Lock, M.⁴

9
- 37549033111
- Effi cacy and tolerability of desvenlafaxine succinate treatment for menopausal vasomotor symptoms: A randomized controlled trial
- Speroff L, Gass M, Constantine G, Olivier S. Effi cacy and tolerability of desvenlafaxine succinate treatment for menopausal vasomotor symptoms: a randomized controlled trial. Obstet Gynecol 2008;111:77-87
- (2008) Obstet Gynecol , vol.111 , pp. 77-87
- Speroff, L.¹ Gass, M.² Constantine, G.³ Olivier, S.⁴

10
- 33646858444
- Menopause and Hormones. Retrieved July 8 2011, from
- Menopause and Hormones. US Department of Health and Human Resources, 2009. Retrieved July 8, 2011, from http://www. fda.gov/forconsumers/byaudience/ forwomen/ucm118624.htm
- (2009) US Department of Health and Human Resources

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.